You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Best Practices in the Management of Reflux Disease: Experts Discuss Patient Cases

  • Authors: A. Pali Hungin, MD, FRCP, FRCGP; Peter J. Kahrilas, MD; Juan M. Mendive, MD, PhD
  • CPD Released: 8/4/2021; Reviewed and Renewed: 12/15/2022
  • Valid for credit through: 12/15/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.50 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US primary care physicians, gastroenterologists, and pharmacists.

The goal of this activity is to educate health care providers (HCPs) about the role of alginate/antacid therapy and proton pump inhibitors (PPIs) in the management of reflux disease.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Benefits and limitations of PPIs for the management of reflux disease
    • Recent developments with alginate/antacid therapy for the management of symptoms resulting from acid reflux
  • Have greater competence related to
    • Selection of the most appropriate therapy for the patient with acid reflux disease


Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


Moderator

  • A. Pali Hungin, MD, FRCP, FRCGP

    Professor of Primary Care and General Practice
    The Institute of Health and Society
    Faculty of Medical Sciences
    Newcastle University
    Steering Committee member of ESPCG
    Newcastle upon Tyne, United Kingdom

    Disclosures

    Disclosure: A. Pali Hungin, MD FRCP FRCGP, has the following relevant financial relationships:
    Advisor or consultant for: Reckitt Benkiser
    Speaker or a member of a speakers bureau for: Reckitt Benkiser; Sandoz; Tillotts
    Other: Non Exec Director for a UK National Health Trust

Faculty

  • Peter J. Kahrilas, MD

    Professor of Medicine (Gastroenterology and Hepatology)
    Division of Gastroenterology
    Department of Medicine
    Northwestern University
    Chicago, Illinois, United States

    Disclosures

    Disclosure: Peter J. Kahrilas, MD, has the following relevant financial relationships:
    Advisor or consultant for: Ironwood Pharmaceuticals; Reckitt Benkiser
    Grants for clinical research from: Ironwood Pharmaceuticals

  • Juan M. Mendive, MD, PhD

    La Mina Primary Health Care Centre
    Sant Adrià de Besòs
    Barcelona, Spain
    Chair of ESPCG
    Catalan Institut of Health
    University of Barcelona
    Barcelona, Spain

    Disclosures

    Disclosure: Juan M. Mendive, MD, PhD, has the following relevant financial relationships:
    Advisor or consultant for: Reckitt Benkiser

Editor

  • Alessia Piazza, PhD

    Medical Education Director, WebMD Global, LLC 

    Disclosures

    Disclosure: Alessia Piazza, PhD, has disclosed no relevant financial relationships.  

Content Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Johnson and Johnson; Neurogastrix


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Best Practices in the Management of Reflux Disease: Experts Discuss Patient Cases

Authors: A. Pali Hungin, MD, FRCP, FRCGP; Peter J. Kahrilas, MD; Juan M. Mendive, MD, PhDFaculty and Disclosures

CPD Released: 8/4/2021; Reviewed and Renewed: 12/15/2022

Valid for credit through: 12/15/2023

processing....

Educational Impact Challenge

The goal of this activity is to educate health care providers (HCPs) about the role of alginate/antacid therapy and proton pump inhibitors (PPIs) in the management of reflux disease.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print